genedrive (LON:GDR) Stock Price Down 4.2% – Time to Sell?

genedrive plc (LON:GDR) traded down 4.2% during mid-day trading on Monday . The stock traded as low as GBX 1.07 and last traded at GBX 1.15. 3,327,936 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 7,263,405 shares. The stock had previously closed at GBX 1.20.

genedrive Stock Performance

The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52. The stock has a market capitalization of £11.83 million, a PE ratio of -1.28 and a beta of -0.04. The firm has a fifty day moving average price of GBX 0.97 and a two-hundred day moving average price of GBX 0.80.

genedrive (LON:GDR) last posted its quarterly earnings data on Monday, February 16th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. genedrive had a negative net margin of 1,412.18% and a negative return on equity of 191.22%. Research analysts expect that genedrive plc will post 209.9999867 EPS for the current year.

About genedrive

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.